Neoplasms
|
group |
Neoplasms
|
Neoplastic Process
|
10161
|
1644
|
0.200 |
None |
0.964 |
138 |
5
|
1994 |
2020 |
Malignant Neoplasms
|
group |
Neoplasms
|
Neoplastic Process
|
8621
|
1641
|
0.400 |
None |
0.984 |
63 |
4
|
1988 |
2020 |
Kallmann Syndrome
|
disease |
Congenital, Hereditary, and Neonatal Diseases and Abnormalities; Female Urogenital Diseases and Pregnancy Complications; Male Urogenital Diseases; Endocrine System Diseases
|
Disease or Syndrome
|
86
|
30
|
0.600 |
None |
0.979 |
48 |
10
|
2003 |
2019 |
Primary malignant neoplasm
|
group |
Neoplasms
|
Neoplastic Process
|
8221
|
1374
|
0.100 |
None |
0.979 |
48 |
4
|
1988 |
2020 |
Breast Carcinoma
|
disease |
Neoplasms; Skin and Connective Tissue Diseases
|
Neoplastic Process
|
6776
|
2793
|
0.600 |
None |
0.977 |
44 |
1
|
1994 |
2020 |
Malignant neoplasm of breast
|
disease |
Neoplasms; Skin and Connective Tissue Diseases
|
Neoplastic Process
|
6941
|
3417
|
0.600 |
None |
0.976 |
42 |
1
|
1999 |
2020 |
Myeloproliferative disease
|
group |
Hemic and Lymphatic Diseases
|
Neoplastic Process
|
365
|
43
|
0.400 |
None |
0.975 |
40 |
|
1998 |
2018 |
Non-Small Cell Lung Carcinoma
|
disease |
Neoplasms; Respiratory Tract Diseases
|
Neoplastic Process
|
3926
|
712
|
0.400 |
None |
0.917 |
36 |
|
1999 |
2020 |
Myeloid/Lymphoid Neoplasms with FGFR1 Rearrangement
|
disease |
|
Neoplastic Process
|
22
|
|
0.100 |
None |
0.971 |
35 |
|
1999 |
2019 |
Kallmann Syndrome 2 (disorder)
|
disease |
Congenital, Hereditary, and Neonatal Diseases and Abnormalities; Female Urogenital Diseases and Pregnancy Complications; Male Urogenital Diseases; Endocrine System Diseases
|
Disease or Syndrome
|
8
|
45
|
0.720 |
strong |
0.971 |
34 |
42
|
1994 |
2017 |
Chronic myeloproliferative disorder
|
disease |
Neoplasms; Hemic and Lymphatic Diseases
|
Neoplastic Process
|
366
|
47
|
0.100 |
None |
1.000 |
34 |
|
1998 |
2018 |
Malignant neoplasm of lung
|
disease |
Neoplasms; Respiratory Tract Diseases
|
Neoplastic Process
|
4173
|
1142
|
0.400 |
None |
0.970 |
33 |
|
2011 |
2019 |
Carcinoma of lung
|
disease |
Neoplasms; Respiratory Tract Diseases
|
Neoplastic Process
|
4081
|
1204
|
0.100 |
None |
1.000 |
30 |
|
2012 |
2019 |
Pfeiffer Syndrome
|
disease |
Congenital, Hereditary, and Neonatal Diseases and Abnormalities; Musculoskeletal Diseases
|
Disease or Syndrome
|
8
|
36
|
0.900 |
None |
1.000 |
29 |
6
|
1994 |
2020 |
Squamous cell carcinoma of lung
|
disease |
Neoplasms; Respiratory Tract Diseases
|
Neoplastic Process
|
670
|
283
|
0.400 |
None |
0.966 |
29 |
|
2010 |
2019 |
Middle Cerebral Artery Occlusion
|
disease |
Pathological Conditions, Signs and Symptoms; Nervous System Diseases; Cardiovascular Diseases
|
Acquired Abnormality
|
626
|
|
0.100 |
None |
1.000 |
29 |
|
2016 |
2020 |
Primary malignant neoplasm of lung
|
disease |
Neoplasms; Respiratory Tract Diseases
|
Neoplastic Process
|
3894
|
981
|
0.100 |
None |
1.000 |
29 |
|
2012 |
2019 |
Neoplasm Metastasis
|
phenotype |
Pathological Conditions, Signs and Symptoms; Neoplasms
|
Neoplastic Process
|
6385
|
327
|
0.100 |
None |
1.000 |
27 |
|
2005 |
2019 |
Tumor Cell Invasion
|
phenotype |
|
Neoplastic Process
|
6626
|
169
|
0.100 |
None |
0.960 |
25 |
|
2007 |
2020 |
Squamous cell carcinoma
|
disease |
Neoplasms
|
Neoplastic Process
|
2507
|
257
|
0.400 |
None |
0.917 |
24 |
|
2008 |
2018 |
Idiopathic hypogonadotropic hypogonadism
|
disease |
Endocrine System Diseases
|
Disease or Syndrome
|
82
|
66
|
0.500 |
strong |
1.000 |
22 |
12
|
2006 |
2020 |
Adenocarcinoma
|
group |
Neoplasms
|
Neoplastic Process
|
2235
|
168
|
0.100 |
None |
1.000 |
19 |
|
2001 |
2019 |
Craniosynostosis
|
disease |
Congenital, Hereditary, and Neonatal Diseases and Abnormalities; Musculoskeletal Diseases
|
Disease or Syndrome
|
488
|
90
|
0.700 |
strong |
0.941 |
17 |
4
|
1995 |
2018 |
CHROMOSOME 8p11 MYELOPROLIFERATIVE SYNDROME
|
disease |
|
Disease or Syndrome
|
17
|
|
0.400 |
None |
1.000 |
17 |
|
1999 |
2020 |
Glioblastoma
|
disease |
Neoplasms
|
Neoplastic Process
|
3177
|
281
|
0.200 |
None |
0.882 |
17 |
3
|
1994 |
2019 |